Intact Triple-Helical Collagen: The Kollagen™ Difference
Evidence-based practice and literature show the benefit and importance of intact triple-helical collagen in skin repair, tissue repair, and wound healing. Human BioSciences is continuously researching ways to extend the near-certain wound healing progress of our Kollagen™ branded products to the wound repair, skincare, and cosmetic market space. Our trademark protein technology when paired with cutting-edge delivery mechanisms, provides superiority in bioactive collagen-based products. Because we have mastered skin proteins, we can design and deliver ECM peptides at therapeutic doses in the form of various premier beauty and rejuvenation products. Human BioSciences takes pride in combining outcome-based research products with deliverable perception-driven marketing of Kollagen™ Technology Advanced Wound Care, Skincare, and Beauty products.
Native collagen type I can be extracted from different sources, however, the main source of extraction is bovine because of its availability as well as its biocompatibility. Collagen extraction can be carried out from different tissues such as bones, tendons, lung tissue, or even connective tissue. Native is collagen in its “purest form”. Non-hydrolyzed collagen retains significantly more native triple helical protein structure, therefore allowing superior stability of the molecule and scaffolding in wound healing. It is vital that collagen retains its triple helix shape to enhance thermal durability, mechanical strength, and ability to engage in precise interactions with other biomolecules.
Journal Articles
Biotechnol Appl Biochem. 1999 Oct;30 ( Pt 2):129-37.Dermal and transdermal delivery of protein pharmaceuticals: lipid-based delivery systems for interferon alpha. Foldvari M1, Baca-Estrada ME, He Z, Hu J, Attah-Poku S, King M.
Crit Rev Ther Drug Carrier Syst. 2012;29(4):265-98.Transcending the skin barrier to deliver peptides and proteins using active technologies. Singh N1, Kalluri H, Herwadkar A, Badkar A, Banga AK.
Vaccine. 2007 Jun 6;25(23):4564-70. Epub 2007 Apr 25.Immunological activation following transcutaneous delivery of HR-gp100 protein. Frankenburg S1, Grinberg I, Bazak Z, Fingerut L, Pitcovski J, Gorodetsky R, Peretz T, Spira RM, Skornik Y, Goldstein RS.
Int J Biol Macromol 2017 Apr;97:55-66. doi: 10.1016/j.ijbiomac.2016.12.068. Epub 2016 Dec 27. Collagen type I from bovine bone. Effect of animal age, bone anatomy and drying methodology on extraction yield, self-assembly, thermal behaviour and electrokinetic potential. Vincenza Ferraro, Brigitte Gaillard-Martinie, Thierry Sayd, Christophe Chambon, Marc Anton, Véronique Santé-Lhoutellier
Subscribe to our newsletter
Join today and stay updated
Company
Education
Customer Service
Ridley Vann
Mr. Vann oversees E-Commerce, Inventory, and Facilities, ensuring optimal product and supply management across medical, nutraceutical, and cosmetic lines.
With a dedication to accuracy and reliability, he brings a wealth of experience as an innovative project coordinator adept at managing diverse initiatives and streamlining processes.
He holds a Bachelor’s of Science Degree in Environmental Science and Technology from the University of Maryland and started his career at the Smithsonian Institution, spearheading green initiatives for the annual Folklife Festival with the Metropolitan Washington Council of Governments.
Nisha Jain Vann
Creative Director, Human BioSciences
Mrs. Vann is responsible for branding, design, and public outreach efforts for the company.
Mrs. Vann has over five years of experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international.
She also has experience producing several television and live-stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.
Jack Slovick
Mr. Slovick is responsible for all regulatory and quality affairs in the company.
Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years.
He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.
Jigar Patel
Vice President of Operations, Human BioSciences
Mr. Patel is the Vice President of Operations for Human BioSciences. As such, he is responsible for strategy development for optimal growth, organizing multiple teams and implementing optimal product delivery for the growth of HBS.
He has served multiple positions within HBS since 2001, including Operations Manager.
With an MBA in Pharmaceutical Healthcare and a Bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge in collagen product production with a rich history in managing teams.
David H. Dickieson
General Counsel
Mr. Dickieson, as General Counsel, is involved with Human Biosciences’ efforts to expand internationally while aiding with growth and legal compliance in the U.S.
He has over 40 years of experience as a trial attorney with the U.S. Department of Justice and with Washington, D.C. law firms. His law degree is from the University of Michigan and he received a Bachelors Degree in Government from Cornell.
Dr. Rohan K Jain
President, Human BioSciences
As the President of Human BioSciences, Dr. Rohan K Jain is responsible for the company’s overall operations, with a focus on research and development.
Dr. Jain has supervised and conducted extensive research in the collagen, biomaterials, and protein space, resulting in the release of numerous new products to the market.
Prior to his role at HBS, Dr. Jain was a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University; his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.